Aspirin has been a secondary prevention for stroke and heart attack but FDA said evidence is not enough to consider it as a primary prevention. Bayer maintains that FDA approved aspirin to numerous cardiovascular indications and those who are in an aspirin regimen should consult with their healthcare provider.